Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Serum amyloid A expression in liver promotes synovial macrophage activation and chronic arthritis via NFAT5
Meiling Li, Yu-Mi Kim, Jung Hee Koh, Jihyun Park, H. Moo Kwon, Jong-Hwan Park, Jingchun Jin, Youngjae Park, Donghyun Kim, Wan-Uk Kim
Meiling Li, Yu-Mi Kim, Jung Hee Koh, Jihyun Park, H. Moo Kwon, Jong-Hwan Park, Jingchun Jin, Youngjae Park, Donghyun Kim, Wan-Uk Kim
View: Text | PDF
Research Article Autoimmunity Inflammation

Serum amyloid A expression in liver promotes synovial macrophage activation and chronic arthritis via NFAT5

  • Text
  • PDF
Abstract

Nuclear factor of activated T-cells 5 (NFAT5), an osmo-sensitive transcription factor, can be activated by isotonic stimuli, such as infection. It remains unclear, however, whether NFAT5 is required for damage-associated molecular pattern–triggered (DAMP-triggered) inflammation and immunity. Here, we found that several DAMPs increased NFAT5 expression in macrophages. In particular, serum amyloid A (SAA), primarily generated by the liver, substantially upregulated NFAT5 expression and activity through TLR2/4-JNK signalling pathway. Moreover, the SAA-TLR2/4-NFAT5 axis promoted migration and chemotaxis of macrophages in an IL-6– and chemokine ligand 2–dependent (CCL2-dependent) manner in vitro. Intraarticular injection of SAA markedly accelerated macrophage infiltration and arthritis progression in mice. By contrast, genetic ablation of NFAT5 or TLR2/4 rescued the pathology induced by SAA, confirming the SAA-TLR2/4-NFAT5 axis in vivo. Myeloid-specific depletion of NFAT5 also attenuated SAA-accelerated arthritis. Of note, inflammatory arthritis in mice strikingly induced SAA overexpression in the liver. Conversely, forced overexpression of the SAA gene in the liver accelerated joint damage, indicating that the liver contributes to bolstering chronic inflammation at remote sites by secreting SAA. Collectively, this study underscores the importance of the SAA-TLR2/4-NFAT5 axis in innate immunity, suggesting that acute phase reactant SAA mediates mutual interactions between liver and joints and ultimately aggravates chronic arthritis by enhancing macrophage activation.

Authors

Meiling Li, Yu-Mi Kim, Jung Hee Koh, Jihyun Park, H. Moo Kwon, Jong-Hwan Park, Jingchun Jin, Youngjae Park, Donghyun Kim, Wan-Uk Kim

×

Figure 3

Requirement of NFAT5 for SAA-induced macrophage migration.

Options: View larger image (or click on image) Download as PowerPoint
Requirement of NFAT5 for SAA-induced macrophage migration.
(A and B) Imm...
(A and B) Immunocytochemical analysis of F-actin (red) in RAW 264.7 macrophages transfected with NFAT5 shRNA (A) and peritoneal macrophages of Nfat5+/– mice (B), stimulated with SAA (2.5 μg/mL) for 2.5 hours. Nuclei were counterstained with DAPI (blue). Arrows indicate filopodia and lamellipodia. Scale bars: 10 μm. (C) Decrease in SAA-induced wound migration of RAW 264.7 macrophages by NFAT5 knockdown (KD). Scale bar: 400 μm. (D and E) Decrease in transwell migration of NFAT5 KD RAW 264.7 macrophages (D) and Nfat5+/– BMDM (E) stimulated with SAA (5 μg/mL). Scale bars: 500 μm. (F) Macrophage migration in SAA-stimulated air pouch in vivo. After air pouches were established in BALB/c mice, the mice were subjected to i.v. injection of NFAT5 KD or control RAW 264.7 cells (1 × 105) labeled with GFP. After 48 hours, the ratio of GFP+ cells migrating to the air pouch cavity containing SAA (20 μg/mL) were evaluated by flow cytometry. (G and H) Chemotactic migration of macrophages to conditioned media. Conditioned media (SAASup) were harvested from Nfat5-deficient (KD) or -sufficient RAW 264.7 macrophages (G) and BMDM (H) 24 hours after stimulation with SAA (5 μg/mL). Scale bars: 100 μm. Data represent mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 by Brown–Forsythe and Welch’s ANOVA (C, G, and H), 1-way ANOVA test (D and E), and Kruskal-Wallis test (F). Comparison of numerical data between groups were performed using the unpaired t test, Welch’s t test, or Mann-Whitney U test.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts